Skip to main content
Skip to primary sidebar

SUBSCRIBE TO OUR NEWSLETTER TO STAY UP TO DATE ON OUR MODELS AND SERVICES

[email protected]

QPS Neuropharmacology

CRO for CNS Drug Development

Home
About Us
In Vitro Services
In Vivo Services
- - Animal Models
  - Behavioral Tests
Ex Vivo Services
Resources
Contact

Schizophrenia-MK801

Schizophrenia-MK801

January 25, 2023 by

Primary Sidebar

Newsletter

Repeated MPTP injections to model the Parkinson’s disease phenotype September 18, 2023
Fluorescent In Situ Hybridization (FISH) to Analyze Gene Expression August 28, 2023
6-OHDA Injections in Mice to Model Parkinson’s Disease August 7, 2023
Cisterna Magna Injections – Now Available for Preclinical Studies July 17, 2023
LRRK2 G2019S Mice and Rats to Model Parkinson’s Disease June 28, 2023

Request Information

Navigation

Home
About QPS Neuro
Meet the Team
Publications
Clinical Research
QPS Corporate Website
Quality Assurance
Careers
Blog
Imprint (Impressum)
Privacy Policies
Contact

QPS Austria GmbH

Parkring 12, 8074
Grambach, Austria

+43 (0) 316 258111
+43 (0) 316 258111 -300
[email protected]

In Vitro Services

Overview
Cell Culture Models
Cellular Imaging & Analysis
Alzheimer’s Disease Models
Parkinson’s Disease Models
Lesion Induced Models
Neuronal Plasticity
Neuroinflammation
Mitochondria Related Assays

Ex Vivo Services

Overview
Histology Services
Molecular Biology
Biobank

In Vivo Services

Animal Models

In Vivo Services

Behavioral Tests

Other QPS Services

Preclinical
Bioanalysis
Clinical Research

Copyright © 2023 · QPS Neuropharmacology · All Rights ReservedA

Let's Talk!